NeuroThera Labs touts enrollment momentum in SCI-210 autism trial
NeuroThera Labs said it has achieved significant enrollment momentum in its SCI-210 autism clinical trial.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.